C2E: 9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)-3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine-2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin-6-one)
C2E is a Ligand Of Interest in 4FOU designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with same target (top 5) |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
4FOU_C2E_A_701 | 87% | 19% | 0.108 | 0.981 | 1.81 | 1.66 | 5 | 14 | 0 | 0 | 100% | 1 |
4FOU_C2E_B_701 | 87% | 21% | 0.104 | 0.976 | 1.85 | 1.46 | 5 | 10 | 0 | 0 | 100% | 1 |
4FOJ_C2E_A_701 | 94% | 38% | 0.081 | 0.979 | 1.4 | 1.03 | 4 | 3 | 0 | 0 | 100% | 1 |
4FOK_C2E_A_701 | 93% | 38% | 0.084 | 0.977 | 1.27 | 1.18 | 4 | 5 | 0 | 0 | 100% | 1 |
4F3H_C2E_A_501 | 43% | 30% | 0.186 | 0.91 | 0.98 | 1.81 | 2 | 9 | 6 | 0 | 100% | 1 |
4F48_C2E_A_501 | 1% | 32% | 0.506 | 0.631 | 1.25 | 1.45 | 7 | 7 | 8 | 0 | 100% | 0.5 |
8U0I_C2E_A_102 | 100% | 40% | 0.042 | 0.984 | 1.15 | 1.19 | 6 | 6 | 0 | 0 | 100% | 1 |
4RT1_C2E_B_201 | 99% | 17% | 0.054 | 0.982 | 2.38 | 1.24 | 11 | 7 | 0 | 0 | 100% | 1 |
4RT0_C2E_A_202 | 98% | 13% | 0.05 | 0.974 | 2.34 | 1.6 | 11 | 13 | 0 | 0 | 100% | 1 |
4URG_C2E_A_1241 | 97% | 16% | 0.065 | 0.983 | 2.24 | 1.49 | 10 | 10 | 0 | 0 | 100% | 1 |
5HTL_C2E_B_201 | 97% | 17% | 0.057 | 0.973 | 2.34 | 1.3 | 15 | 8 | 1 | 0 | 100% | 1 |